Archive note: The original essay was published October 7, 2023. This summary was revised October 24, 2026 to replace an incomplete excerpt.
What the essay argues
An opinion essay published by The Gradient, and originally appearing in Reboot, questions whether the goals of commercial AI product development are the same as the goals of preventing serious harm. It distinguishes speculative future risks from harms associated with present-day automated decisions.
Why it matters
The essay asks who defines the values an AI system should follow, whose interests those choices serve, and how disagreement should be handled. It presents an argument about incentives and accountability, rather than announcing a new technical result.
MintedBrain take
Read this as a perspective in the AI safety debate. When evaluating an AI deployment, ask which specific harms are being addressed, who could be affected, and how outcomes will be assessed. Keep the author's arguments separate from independently established findings.
Read the original essay at The Gradient.
Discussion
Sign in to comment. Your account must be at least 1 day old.